StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -$2.59. The highest annual figure on record is -$2.02 in fiscal 2023.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.59–
FY2024Dec 31, 2024-$2.56–
FY2023Dec 31, 2023-$2.02–
FY2022Dec 31, 2022-$3.01–
FY2021Dec 31, 2021-$2.69–
FY2020Dec 31, 2020-$4.37–

More CASI Pharmaceuticals figures

See a number that looks wrong?